Myocardial infarction · patients with hypertension
CCBs showed no clear difference in myocardial infarction compared with diuretic (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with hypertension
CCBs showed no clear difference in cardiovascular mortality compared with ARB (moderate certainty).
1 finding from 1 review
Stroke · patients with hypertension
CCBs showed no clear difference in stroke compared with diuretic (moderate certainty).
1 finding from 1 review
Congestive heart failure · patients with hypertension
CCBs probably leads to higher congestive heart failure compared with diuretic (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · patients with hypertension
CCBs showed no clear difference in cardiovascular mortality compared with diuretic (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with hypertension
CCBs showed no clear difference in all‐cause mortality compared with β‐blocker (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with hypertension
CCBs showed no clear difference in myocardial infarction compared with β‐blocker (moderate certainty).
1 finding from 1 review
Stroke · patients with hypertension
CCBs probably leads to lower stroke compared with β‐blocker (moderate certainty).
1 finding from 1 review
Congestive heart failure · patients with hypertension
CCBs showed no clear difference in congestive heart failure compared with β‐blocker (low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia ‐ not improved to a clinically important extent · people with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether the intervention changes tardive dyskinesia ‐ not improved to a clinically important extent (very low certainty).
1 finding from 1 review
Intervention not reported
Tardive dyskinesia ‐ deterioration · people with antipsychotic‐induced tardive dyskinesia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects ‐ any important adverse effects · people with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Intervention not reported
Adverse effects ‐ important extrapyramidal adverse effects · people with antipsychotic‐induced tardive dyskinesia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mental state ‐ deterioration · people with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Intervention not reported
Acceptability of treatment ‐ leaving the study early · people with antipsychotic‐induced tardive dyskinesia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Social confidence, social inclusion, social networks or personalised quality of life measures ‐ no clinically significant change · people with antipsychotic‐induced tardive dyskinesia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Intervention not reported
Duration of attacks · primary Raynaud's phenomenon
1 finding from 1 review
Intervention not reported
Severity scores · primary Raynaud's phenomenon
1 finding from 1 review
Intervention not reported
Patient preference scores · primary Raynaud's phenomenon
1 finding from 1 review